Cingulate executives to discuss pharma launch strategies at Sept. 22 summit
AI Summary- Cingulate executives will join two pharmaceutical commercialization panels at the Indegene Digital Summit.
- September 22, 2026, sessions will take place at Philadelphia’s National Constitution Center.
- CTx-1301 received an FDA Complete Response Letter on June 1, 2026.